Cargando…

CSF Biomarkers Reflecting Protein Pathology and Axonal Degeneration Are Associated with Memory, Attentional, and Executive Functioning in Early-Stage Parkinson′s Disease

In early-stage Parkinson′s disease (PD), cognitive impairment is common, and a variety of cognitive domains including memory, attention, and executive functioning may be affected. Cerebrospinal fluid (CSF) biomarkers are potential markers of cognitive functioning. We aimed to explore whether CSF α-s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oosterveld, Linda P., Kuiper, Tessa I., Majbour, Nour K., Verberk, Inge M. W., van Dijk, Karin D., Twisk, Jos W. R., El-Agnaf, Omar M., Teunissen, Charlotte E., Weinstein, Henry C., Klein, Martin, Berendse, Henk W., van de Berg, Wilma D. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697681/ https://www.ncbi.nlm.nih.gov/pubmed/33198266 http://dx.doi.org/10.3390/ijms21228519

Ejemplares similares

CSF or serum neurofilament light added to α‐Synuclein panel discriminates Parkinson's from controls
por: Oosterveld, Linda P., et al.
Publicado: (2019)

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
por: Majbour, Nour K., et al.
Publicado: (2016)

Preanalytical Stability of CSF Total and Oligomeric Alpha-Synuclein
por: Abdi, Ilham Y., et al.
Publicado: (2021)

CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
por: Majbour, Nour K., et al.
Publicado: (2020)

α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies
por: van Steenoven, Inger, et al.
Publicado: (2018)

Inflammatory Blood Biomarkers Are Associated with Long-Term Clinical Disease Severity in Parkinson’s Disease
por: Hepp, Dagmar H., et al.
Publicado: (2023)

Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
por: Majbour, Nour K., et al.
Publicado: (2017)

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach
por: van Dijk, Karin D., et al.
Publicado: (2010)

Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage
por: Majbour, Nour, et al.
Publicado: (2022)

Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson’s Disease Patients and Is Present within Lewy Bodies
por: Chatterjee, Madhurima, et al.
Publicado: (2020)

Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
por: Parnetti, Lucilla, et al.
Publicado: (2014)

Hyposmia as a marker of (non-)motor disease severity in Parkinson’s disease
por: Roos, Dareia S., et al.
Publicado: (2019)

Cortical and Subcortical Changes in MEG Activity Reflect Parkinson’s Progression over a Period of 7 Years
por: Boon, Lennard I., et al.
Publicado: (2023)

Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive Decline
por: Ebenau, Jarith L., et al.
Publicado: (2022)

COGTIPS: a double-blind randomized active controlled trial protocol to study the effect of home-based, online cognitive training on cognition and brain networks in Parkinson’s disease
por: van Balkom, Tim D., et al.
Publicado: (2019)

Plasma p-tau217: from ‘new kid’ to most promising candidate for Alzheimer’s disease blood test
por: Teunissen, Charlotte E, et al.
Publicado: (2020)

Parkinson’s disease, temporomandibular disorder pain and bruxism and its clinical consequences: a protocol of a single-centre observational outpatient study
por: Verhoeff, Merel Charlotte, et al.
Publicado: (2022)

Resting-state functional connectivity as a marker of disease progression in Parkinson's disease: A longitudinal MEG study()
por: Olde Dubbelink, Kim T.E., et al.
Publicado: (2013)

Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis
por: Chatterjee, Madhurima, et al.
Publicado: (2018)

A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein
por: Landeck, Natalie, et al.
Publicado: (2016)

Visual hallucinations in Parkinson’s disease are associated with thinning of the inner retina
por: Visser, F., et al.
Publicado: (2020)

Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers
por: Vaikath, Nishant, et al.
Publicado: (2022)

Deciphering Protein Secretion from the Brain to Cerebrospinal Fluid for Biomarker Discovery
por: Waury, Katharina, et al.
Publicado: (2023)

Functional connectivity between resting-state networks reflects decline in executive function in Parkinson’s disease: A longitudinal fMRI study
por: Boon, Lennard I., et al.
Publicado: (2020)

A Healthy Brain in a Healthy Body: Brain Network Correlates of Physical and Mental Fitness
por: Douw, Linda, et al.
Publicado: (2014)

New CSF biomarkers on the block
por: Teunissen, Charlotte E, et al.
Publicado: (2016)

Magnetoencephalography to measure the effect of contact point-specific deep brain stimulation in Parkinson’s disease: A proof of concept study
por: Boon, Lennard I., et al.
Publicado: (2023)

Cerebrospinal Fluid α-Synuclein Species in Cognitive and Movements Disorders
por: Constantinides, Vasilios C., et al.
Publicado: (2021)

Orofacial pain and dysfunction in patients with Parkinson's disease: A scoping review
por: Verhoeff, Merel C., et al.
Publicado: (2022)

Clinicians’ view on the management of oral health in Parkinson’s disease patients: a qualitative study
por: Verhoeff, Merel C., et al.
Publicado: (2023)

Relation between carotid stiffness, cognitive performance and brain connectivity in a healthy middle-aged population: an observational neurophysiological cohort study with magnetoencephalography
por: Nieboer, Dagmar, et al.
Publicado: (2016)

Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice
por: Karampetsou, Mantia, et al.
Publicado: (2017)

Cortical axonal loss is associated with both gray matter demyelination and white matter tract pathology in progressive multiple sclerosis: Evidence from a combined MRI-histopathology study
por: Kiljan, Svenja, et al.
Publicado: (2020)

Pre-analytical sample handling effects on blood cytokine levels: quality control of a COVID-19 biobank
por: Verberk, Inge MW, et al.
Publicado: (2021)

Differential insular cortex sub-regional atrophy in neurodegenerative diseases: a systematic review and meta-analysis
por: Fathy, Yasmine Y., et al.
Publicado: (2019)

High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patients
por: Hakkers, Charlotte S., et al.
Publicado: (2020)

Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?
por: Bloniecki, Victor, et al.
Publicado: (2020)

Neurofilament Light Chain Levels in Multiple Sclerosis Correlate With Lesions Containing Foamy Macrophages and With Acute Axonal Damage
por: van den Bosch, Aletta, et al.
Publicado: (2022)

Damaged fiber tracts of the nucleus basalis of Meynert in Parkinson’s disease patients with visual hallucinations
por: Hepp, Dagmar H., et al.
Publicado: (2017)

The Effects of Cognitive Training on Brain Network Activity and Connectivity in Aging and Neurodegenerative Diseases: a Systematic Review
por: van Balkom, Tim D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0mgtmoesh8f9nng7k6i56vd6gq